AstraZeneca paused its US trial on Sept. 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial.
Full ArticleAstraZeneca resumes US COVID-19 vaccine trial as J&J prepares to do same
Jerusalem Post
0 shares
1 views
You might like
Related news coverage
Dangers Of Jumping The Gun On A COVID-19 Vaccine – Analysis
Eurasia Review
By Hannah Clapham*
With COVID-19 cases still rising globally, the race is on for a vaccine. Pressures are mounting to..